Reneurogen LLC

Elm Grove, WI

UEI
JSKMSKNBLN89
CAGE
7RQ01
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Limited Liability Company
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
2160 San Fernando Dr, Elm Grove, WI 53122, USA
Website
rngen.com
Founded
2016
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Reneurogen LLC's 4 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
KYC, an inhibitor of sickle cell disease's vicious cycle in vaso-occlusive crisis and pain - the work in this proposal… Grant · R44HL178153 National Heart Lung and Blood Institute $1,045,688
Development of a systems pharmacology agent for treatment of bronchopulmonary dysplasia - this direct to phase II sbir… Grant · R44HL166018 National Heart Lung and Blood Institute $6,799,236
KYC reduces vasculopathy in sickle cell disease Grant · R43HL139171 National Heart Lung and Blood Institute $274,480
A novel myeloperoxidase inhibitor for treating multiple sclerosis Grant · R43NS105175 National Institute of Neurological Disorders and Stroke $275,285

Quick answers

What is Reneurogen LLC's UEI?

Reneurogen LLC's Unique Entity ID (UEI) in SAM.gov is JSKMSKNBLN89.

What is Reneurogen LLC's CAGE code?

Reneurogen LLC's CAGE code is 7RQ01.

Where is Reneurogen LLC located?

Reneurogen LLC's physical address in SAM.gov is 2160 San Fernando Dr, Elm Grove, WI 53122, USA.

Is Reneurogen LLC registered in SAM.gov?

Yes. Reneurogen LLC's SAM.gov registration is active through September 15, 2027.

What is Reneurogen LLC's most recent federal award?

Reneurogen LLC's most recent federal grant award is KYC, an inhibitor of sickle cell disease's vicious cycle in vaso-occlusive crisis and pain - the work in this proposal… (R44HL178153), from National Heart Lung and Blood Institute, on September 22, 2025.

On GovTribe

See Reneurogen LLC's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login